Up-regulation of pro-inflammatory genes as adaptation to hypoxia in MCF-7 cells and in human mammary invasive carcinoma microenvironment
The role of tumor cells in synthesizing pro‐inflammatory molecules is still controversial. Here we report that hypoxic treatment of the MCF‐7 human mammary adenocarcinoma cell line induced activation of hypoxia‐inducible factor 1α (HIF‐1α) and nuclear factor‐kappa B (NF‐κB). Importantly, hypoxia reg...
Saved in:
| Published in | Cancer science Vol. 101; no. 4; pp. 1014 - 1023 |
|---|---|
| Main Authors | , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Oxford, UK
Blackwell Publishing Ltd
01.04.2010
Blackwell John Wiley & Sons, Inc |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The role of tumor cells in synthesizing pro‐inflammatory molecules is still controversial. Here we report that hypoxic treatment of the MCF‐7 human mammary adenocarcinoma cell line induced activation of hypoxia‐inducible factor 1α (HIF‐1α) and nuclear factor‐kappa B (NF‐κB). Importantly, hypoxia regulated expression of alarmin receptors such as the receptor for advanced glycation end products (RAGE) and the purinoreceptor (P2X7R), and up‐regulated inflammatory response (IR) genes such as the inducible enzymes nitric oxide synthase (NOS2), cycloxygenase (COX2), and the acute‐phase protein pentraxin‐3 (PTX3). Hypoxia also stimulated chemokine (C‐X‐C motif) receptor 4 (CXCR4) mRNA synthesis. In fact, the CXCR4 ligand stromal‐derived factor‐1α (SDF‐1α) increased invasion and migration of hypoxic MCF‐7 cells. Inhibition of HIF‐1α by chetomin and NF‐κB by parthenolide reduced mRNA and protein expression of the studied molecules and prevented invasion of hypoxic MCF‐7 cells. Moreover, solid invasive mammary tumor microenvironment was analyzed after laser‐capture microdissection (LCMD) comparing tumor versus host normal tissue. Nuclear translocation of HIF‐1α and NF‐κB and up‐regulation of IR, CXCR4, estrogen receptor α (ERα), and epithelial growth factor receptor (EGFR) was observed in tumor but not in host normal tissue in the absence of a local inflammatory leukocyte infiltrate. We conclude that under hypoxic conditions MCF‐7 cells acquire a pro‐inflammatory phenotype, and that solid human mammary carcinoma evidenced a similar activation of HIF‐1α, NF‐κB, and IR genes in malignant tumor cells as compared to the normal host tissues. We suggest a role for IR activation in the malignant progression of transformed cells.
(Cancer Sci 2010; 101: 1014–1023) |
|---|---|
| AbstractList | The role of tumor cells in synthesizing pro‐inflammatory molecules is still controversial. Here we report that hypoxic treatment of the MCF‐7 human mammary adenocarcinoma cell line induced activation of hypoxia‐inducible factor 1α (HIF‐1α) and nuclear factor‐kappa B (NF‐κB). Importantly, hypoxia regulated expression of alarmin receptors such as the receptor for advanced glycation end products (RAGE) and the purinoreceptor (P2X7R), and up‐regulated inflammatory response (IR) genes such as the inducible enzymes nitric oxide synthase (NOS2), cycloxygenase (COX2), and the acute‐phase protein pentraxin‐3 (PTX3). Hypoxia also stimulated chemokine (C‐X‐C motif) receptor 4 (CXCR4) mRNA synthesis. In fact, the CXCR4 ligand stromal‐derived factor‐1α (SDF‐1α) increased invasion and migration of hypoxic MCF‐7 cells. Inhibition of HIF‐1α by chetomin and NF‐κB by parthenolide reduced mRNA and protein expression of the studied molecules and prevented invasion of hypoxic MCF‐7 cells. Moreover, solid invasive mammary tumor microenvironment was analyzed after laser‐capture microdissection (LCMD) comparing tumor versus host normal tissue. Nuclear translocation of HIF‐1α and NF‐κB and up‐regulation of IR, CXCR4, estrogen receptor α (ERα), and epithelial growth factor receptor (EGFR) was observed in tumor but not in host normal tissue in the absence of a local inflammatory leukocyte infiltrate. We conclude that under hypoxic conditions MCF‐7 cells acquire a pro‐inflammatory phenotype, and that solid human mammary carcinoma evidenced a similar activation of HIF‐1α, NF‐κB, and IR genes in malignant tumor cells as compared to the normal host tissues. We suggest a role for IR activation in the malignant progression of transformed cells.
(Cancer Sci 2010; 101: 1014–1023) The role of tumor cells in synthesizing pro-inflammatory molecules is still controversial. Here we report that hypoxic treatment of the MCF-7 human mammary adenocarcinoma cell line induced activation of hypoxia-inducible factor 1alpha (HIF-1alpha) and nuclear factor-kappa B (NF-kappaB). Importantly, hypoxia regulated expression of alarmin receptors such as the receptor for advanced glycation end products (RAGE) and the purinoreceptor (P2X7R), and up-regulated inflammatory response (IR) genes such as the inducible enzymes nitric oxide synthase (NOS2), cycloxygenase (COX2), and the acute-phase protein pentraxin-3 (PTX3). Hypoxia also stimulated chemokine (C-X-C motif) receptor 4 (CXCR4) mRNA synthesis. In fact, the CXCR4 ligand stromal-derived factor-1alpha (SDF-1alpha) increased invasion and migration of hypoxic MCF-7 cells. Inhibition of HIF-1alpha by chetomin and NF-kappaB by parthenolide reduced mRNA and protein expression of the studied molecules and prevented invasion of hypoxic MCF-7 cells. Moreover, solid invasive mammary tumor microenvironment was analyzed after laser-capture microdissection (LCMD) comparing tumor versus host normal tissue. Nuclear translocation of HIF-1alpha and NF-kappaB and up-regulation of IR, CXCR4, estrogen receptor alpha (ERalpha), and epithelial growth factor receptor (EGFR) was observed in tumor but not in host normal tissue in the absence of a local inflammatory leukocyte infiltrate. We conclude that under hypoxic conditions MCF-7 cells acquire a pro-inflammatory phenotype, and that solid human mammary carcinoma evidenced a similar activation of HIF-1alpha, NF-kappaB, and IR genes in malignant tumor cells as compared to the normal host tissues. We suggest a role for IR activation in the malignant progression of transformed cells.The role of tumor cells in synthesizing pro-inflammatory molecules is still controversial. Here we report that hypoxic treatment of the MCF-7 human mammary adenocarcinoma cell line induced activation of hypoxia-inducible factor 1alpha (HIF-1alpha) and nuclear factor-kappa B (NF-kappaB). Importantly, hypoxia regulated expression of alarmin receptors such as the receptor for advanced glycation end products (RAGE) and the purinoreceptor (P2X7R), and up-regulated inflammatory response (IR) genes such as the inducible enzymes nitric oxide synthase (NOS2), cycloxygenase (COX2), and the acute-phase protein pentraxin-3 (PTX3). Hypoxia also stimulated chemokine (C-X-C motif) receptor 4 (CXCR4) mRNA synthesis. In fact, the CXCR4 ligand stromal-derived factor-1alpha (SDF-1alpha) increased invasion and migration of hypoxic MCF-7 cells. Inhibition of HIF-1alpha by chetomin and NF-kappaB by parthenolide reduced mRNA and protein expression of the studied molecules and prevented invasion of hypoxic MCF-7 cells. Moreover, solid invasive mammary tumor microenvironment was analyzed after laser-capture microdissection (LCMD) comparing tumor versus host normal tissue. Nuclear translocation of HIF-1alpha and NF-kappaB and up-regulation of IR, CXCR4, estrogen receptor alpha (ERalpha), and epithelial growth factor receptor (EGFR) was observed in tumor but not in host normal tissue in the absence of a local inflammatory leukocyte infiltrate. We conclude that under hypoxic conditions MCF-7 cells acquire a pro-inflammatory phenotype, and that solid human mammary carcinoma evidenced a similar activation of HIF-1alpha, NF-kappaB, and IR genes in malignant tumor cells as compared to the normal host tissues. We suggest a role for IR activation in the malignant progression of transformed cells. The role of tumor cells in synthesizing pro-inflammatory molecules is still controversial. Here we report that hypoxic treatment of the MCF-7 human mammary adenocarcinoma cell line induced activation of hypoxia-inducible factor 1alpha (HIF-1alpha) and nuclear factor-kappa B (NF-kappaB). Importantly, hypoxia regulated expression of alarmin receptors such as the receptor for advanced glycation end products (RAGE) and the purinoreceptor (P2X7R), and up-regulated inflammatory response (IR) genes such as the inducible enzymes nitric oxide synthase (NOS2), cycloxygenase (COX2), and the acute-phase protein pentraxin-3 (PTX3). Hypoxia also stimulated chemokine (C-X-C motif) receptor 4 (CXCR4) mRNA synthesis. In fact, the CXCR4 ligand stromal-derived factor-1alpha (SDF-1alpha) increased invasion and migration of hypoxic MCF-7 cells. Inhibition of HIF-1alpha by chetomin and NF-kappaB by parthenolide reduced mRNA and protein expression of the studied molecules and prevented invasion of hypoxic MCF-7 cells. Moreover, solid invasive mammary tumor microenvironment was analyzed after laser-capture microdissection (LCMD) comparing tumor versus host normal tissue. Nuclear translocation of HIF-1alpha and NF-kappaB and up-regulation of IR, CXCR4, estrogen receptor alpha (ERalpha), and epithelial growth factor receptor (EGFR) was observed in tumor but not in host normal tissue in the absence of a local inflammatory leukocyte infiltrate. We conclude that under hypoxic conditions MCF-7 cells acquire a pro-inflammatory phenotype, and that solid human mammary carcinoma evidenced a similar activation of HIF-1alpha, NF-kappaB, and IR genes in malignant tumor cells as compared to the normal host tissues. We suggest a role for IR activation in the malignant progression of transformed cells. The role of tumor cells in synthesizing pro‐inflammatory molecules is still controversial. Here we report that hypoxic treatment of the MCF‐7 human mammary adenocarcinoma cell line induced activation of hypoxia‐inducible factor 1α (HIF‐1α) and nuclear factor‐kappa B (NF‐κB). Importantly, hypoxia regulated expression of alarmin receptors such as the receptor for advanced glycation end products (RAGE) and the purinoreceptor (P2X7R), and up‐regulated inflammatory response (IR) genes such as the inducible enzymes nitric oxide synthase (NOS2), cycloxygenase (COX2), and the acute‐phase protein pentraxin‐3 (PTX3). Hypoxia also stimulated chemokine (C‐X‐C motif) receptor 4 (CXCR4) mRNA synthesis. In fact, the CXCR4 ligand stromal‐derived factor‐1α (SDF‐1α) increased invasion and migration of hypoxic MCF‐7 cells. Inhibition of HIF‐1α by chetomin and NF‐κB by parthenolide reduced mRNA and protein expression of the studied molecules and prevented invasion of hypoxic MCF‐7 cells. Moreover, solid invasive mammary tumor microenvironment was analyzed after laser‐capture microdissection (LCMD) comparing tumor versus host normal tissue. Nuclear translocation of HIF‐1α and NF‐κB and up‐regulation of IR, CXCR4, estrogen receptor α (ERα), and epithelial growth factor receptor (EGFR) was observed in tumor but not in host normal tissue in the absence of a local inflammatory leukocyte infiltrate. We conclude that under hypoxic conditions MCF‐7 cells acquire a pro‐inflammatory phenotype, and that solid human mammary carcinoma evidenced a similar activation of HIF‐1α, NF‐κB, and IR genes in malignant tumor cells as compared to the normal host tissues. We suggest a role for IR activation in the malignant progression of transformed cells. ( Cancer Sci 2010; 101: 1014–1023) The role of tumor cells in synthesizing pro‐inflammatory molecules is still controversial. Here we report that hypoxic treatment of the MCF‐7 human mammary adenocarcinoma cell line induced activation of hypoxia‐inducible factor 1α (HIF‐1α) and nuclear factor‐kappa B (NF‐κB). Importantly, hypoxia regulated expression of alarmin receptors such as the receptor for advanced glycation end products (RAGE) and the purinoreceptor (P2X7R), and up‐regulated inflammatory response (IR) genes such as the inducible enzymes nitric oxide synthase (NOS2), cycloxygenase (COX2), and the acute‐phase protein pentraxin‐3 (PTX3). Hypoxia also stimulated chemokine (C‐X‐C motif) receptor 4 (CXCR4) mRNA synthesis. In fact, the CXCR4 ligand stromal‐derived factor‐1α (SDF‐1α) increased invasion and migration of hypoxic MCF‐7 cells. Inhibition of HIF‐1α by chetomin and NF‐κB by parthenolide reduced mRNA and protein expression of the studied molecules and prevented invasion of hypoxic MCF‐7 cells. Moreover, solid invasive mammary tumor microenvironment was analyzed after laser‐capture microdissection (LCMD) comparing tumor versus host normal tissue. Nuclear translocation of HIF‐1α and NF‐κB and up‐regulation of IR, CXCR4, estrogen receptor α (ERα), and epithelial growth factor receptor (EGFR) was observed in tumor but not in host normal tissue in the absence of a local inflammatory leukocyte infiltrate. We conclude that under hypoxic conditions MCF‐7 cells acquire a pro‐inflammatory phenotype, and that solid human mammary carcinoma evidenced a similar activation of HIF‐1α, NF‐κB, and IR genes in malignant tumor cells as compared to the normal host tissues. We suggest a role for IR activation in the malignant progression of transformed cells. (Cancer Sci 2010; 101: 1014–1023) |
| Author | BRACAGLIA Roberto PELLEGRINI Laura TAFANI Marco SALE Patrizio MARANDINO Ferdinando RUSSO Andrea DI VITO Maura SCHITO Luana GENTILESCHI Stefano GARACI Enrico RUSSO Matteo A |
| AuthorAffiliation | 3 Department of Experimental Medicine, Sapienza University of Rome, Rome 4 Institute of Plastic Surgery, Catholic University, Rome 2 Department of Surgical Pathology, IRCCS Regina Elena, IFO, Rome 5 Department of Experimental Medicine and Biochemical Science, University of Rome “Tor Vergata”#148;, Rome, Italy 1 Department of Cellular and Molecular Pathology, IRCCS San Raffaele Pisana, Rome |
| AuthorAffiliation_xml | – name: 4 Institute of Plastic Surgery, Catholic University, Rome – name: 1 Department of Cellular and Molecular Pathology, IRCCS San Raffaele Pisana, Rome – name: 2 Department of Surgical Pathology, IRCCS Regina Elena, IFO, Rome – name: 3 Department of Experimental Medicine, Sapienza University of Rome, Rome – name: 5 Department of Experimental Medicine and Biochemical Science, University of Rome “Tor Vergata”#148;, Rome, Italy |
| Author_xml | – sequence: 1 givenname: Marco surname: Tafani fullname: Tafani, Marco – sequence: 2 givenname: Andrea surname: Russo fullname: Russo, Andrea – sequence: 3 givenname: Maura surname: Di Vito fullname: Di Vito, Maura – sequence: 4 givenname: Patrizio surname: Sale fullname: Sale, Patrizio – sequence: 5 givenname: Laura surname: Pellegrini fullname: Pellegrini, Laura – sequence: 6 givenname: Luana surname: Schito fullname: Schito, Luana – sequence: 7 givenname: Stefano surname: Gentileschi fullname: Gentileschi, Stefano – sequence: 8 givenname: Roberto surname: Bracaglia fullname: Bracaglia, Roberto – sequence: 9 givenname: Ferdinando surname: Marandino fullname: Marandino, Ferdinando – sequence: 10 givenname: Enrico surname: Garaci fullname: Garaci, Enrico – sequence: 11 givenname: Matteo A surname: Russo fullname: Russo, Matteo A |
| BackLink | https://cir.nii.ac.jp/crid/1571135650973435136$$DView record in CiNii http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22963651$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20151982$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkstu1DAUhiNURC_wCsgSIFYZfIsdLwBVoxaQilhA15bjODMeJXawk2HmDXjsOs20QBeoUZRY9vf_5-Jzmh0570yWAQQXKD3vNgtEqMg5hGyBYdqFiAqy2D3JTu4Pjm7XPBeQ4OPsNMYNhIRRQZ9lx0lTIFHik-z3dZ8HsxpbNVjvgG9AH3xuXdOqrlODD3uwMs5EoNJbq36YucGD9b73O6uAdeDr8jLnQJu2TZCrp6312CkHuskkWVi3VdFuDdAqaOt8p0BndfDGbW3wrjNueJ49bVQbzYvD_yy7vrz4sfycX3379GV5fpVrxgXJa1VzTrFADadVzUuISGVqpQwVqMIKmkobVBQaNbXWTFU15rguDK8YU7ysCTnLPs6-_Vh1ptYpdFCt7IOdMpVeWfnvibNrufJbmfpeCExxcnh7cAj-52jiIDsbp-KVM36MktNSUE4gS-SrB-TGj8Gl8iRBGHEBS1b8j8IlQwUvS04T9fLvvO8TvrvKBLw5ACpq1TZBOW3jHw4LRliBEvdh5lL_YwymkdrOt5rKta1EcCoVyY2cRklOozQFgfJ2xuQuGZQPDO5iPEL6fpb-sq3ZP1onl-ffp1XSv571ztqU9vRN_UGIFKyAghNKUoGM3ADMsfSH |
| CitedBy_id | crossref_primary_10_1016_j_heliyon_2024_e37792 crossref_primary_10_1089_ars_2017_7420 crossref_primary_10_3390_ijms221910701 crossref_primary_10_1007_s10534_012_9586_y crossref_primary_10_1016_j_bbagen_2013_11_014 crossref_primary_10_1074_jbc_M111_219733 crossref_primary_10_1186_1476_4598_11_80 crossref_primary_10_1002_ijc_26032 crossref_primary_10_1073_pnas_1401799111 crossref_primary_10_61186_rbmb_12_4_664 crossref_primary_10_1155_2019_7935310 crossref_primary_10_1016_j_bbcan_2017_11_004 crossref_primary_10_1021_mp200279p crossref_primary_10_3389_fphar_2020_00793 crossref_primary_10_3390_ijms21082660 crossref_primary_10_1089_ars_2016_6811 crossref_primary_10_1038_bjc_2013_348 crossref_primary_10_1016_j_jneuroim_2013_04_009 crossref_primary_10_1016_j_biopha_2022_113783 crossref_primary_10_3390_ijms22020843 crossref_primary_10_1038_onc_2011_365 crossref_primary_10_1016_j_bioorg_2023_106642 crossref_primary_10_3389_fonc_2019_00021 crossref_primary_10_1016_j_biopha_2012_08_003 crossref_primary_10_1038_srep13605 crossref_primary_10_1371_journal_pone_0096250 crossref_primary_10_3390_ijms232214173 crossref_primary_10_3390_ijms17101669 crossref_primary_10_4236_jct_2014_510097 crossref_primary_10_1016_j_ccr_2011_11_017 crossref_primary_10_1016_j_abb_2019_05_025 crossref_primary_10_1016_j_biopha_2024_116342 crossref_primary_10_1152_japplphysiol_00237_2014 crossref_primary_10_1155_2016_3907147 crossref_primary_10_1016_j_gmit_2015_05_001 crossref_primary_10_1021_jf2052515 crossref_primary_10_1021_pr2012347 crossref_primary_10_1186_1742_2094_8_32 crossref_primary_10_1016_j_molstruc_2018_09_072 crossref_primary_10_1093_carcin_bgr101 crossref_primary_10_1016_j_humpath_2017_03_019 crossref_primary_10_1016_j_oraloncology_2018_03_004 crossref_primary_10_1016_j_intimp_2024_112332 crossref_primary_10_1007_s00109_011_0855_y crossref_primary_10_1016_j_bbcan_2017_05_004 crossref_primary_10_4137_CGM_S24314 crossref_primary_10_1002_path_4181 crossref_primary_10_1016_j_fsi_2019_09_073 crossref_primary_10_2217_fon_13_92 |
| Cites_doi | 10.1016/S0092-8674(00)81318-5 10.1038/nrd2781 10.1038/nrm1368 10.1007/s11912-009-0019-1 10.1245/s10434-008-0237-z 10.1038/nrc780 10.1038/nri887 10.1038/nrc1187 10.3858/emm.2009.41.1.007 10.2353/ajpath.2009.080240 10.1152/physiol.00031.2008 10.1016/j.molmed.2009.04.002 10.1016/j.tips.2007.07.002 10.1089/ars.2005.7.395 10.1002/jcp.21666 10.1038/nature06905 10.1074/jbc.M706407200 10.1016/j.neulet.2008.08.057 10.1074/jbc.M001235200 10.1016/j.ejphar.2009.01.026 10.1159/000092969 10.1038/35065016 10.1016/j.freeradbiomed.2009.03.027 10.1146/annurev.immunol.021908.132641 10.1002/pros.20966 10.4161/auto.7070 10.1177/1933719108316390 10.1093/carcin/bgn228 10.1038/nature08021 10.1016/j.joen.2008.02.013 10.1111/j.1525-1438.2007.01089.x 10.1158/0008-5472.CAN-04-1303 10.1002/biof.21 10.1038/nature02924 10.1002/iub.93 10.1016/j.mrrev.2008.03.002 10.1128/MCB.22.8.2862-2870.2002 10.1084/jem.20040624 10.1158/0008-5472.CAN-08-0410 10.1038/nri2215 |
| ContentType | Journal Article |
| Copyright | 2010 Japanese Cancer Association 2015 INIST-CNRS Copyright John Wiley & Sons, Inc. Apr 2010 Copyright John Wiley & Sons, Inc. 2010 |
| Copyright_xml | – notice: 2010 Japanese Cancer Association – notice: 2015 INIST-CNRS – notice: Copyright John Wiley & Sons, Inc. Apr 2010 – notice: Copyright John Wiley & Sons, Inc. 2010 |
| DBID | RYH AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM |
| DOI | 10.1111/j.1349-7006.2010.01493.x |
| DatabaseName | CiNii Complete CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection (via ProQuest) ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection Medical Database Biological Science Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) ProQuest Central China MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database Publicly Available Content Database CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Tafani et al |
| EISSN | 1349-7006 |
| EndPage | 1023 |
| ExternalDocumentID | PMC11159242 20151982 22963651 10_1111_j_1349_7006_2010_01493_x CAS1493 10026591346 |
| Genre | article Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | United States--US |
| GeographicLocations_xml | – name: United States--US |
| GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1OC 24P 29B 2WC 31~ 36B 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52W 52X 5GY 5HH 5LA 5VS 66C 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 88E 8FI 8FJ 8UM 930 A01 A03 AAFWJ AAHHS AAZKR ABCQN ABUWG ACCFJ ACCMX ADBBV ADKYN ADPDF ADZMN ADZOD AEEZP AENEX AEQDE AFBPY AFEBI AFKRA AFPKN AFZJQ AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN BAWUL BBNVY BENPR BFHJK BHPHI BY8 CAG CCPQU COF CS3 D-6 D-7 D-E D-F DR2 DU5 E3Z EBS EJD EMB EMOBN EX3 F00 F01 F04 F5P FIJ FYUFA GODZA GROUPED_DOAJ HCIFZ HF~ HMCUK HOLLA HZI HZ~ IX1 J0M K.9 K48 KQ8 LC2 LC3 LH4 LP6 LP7 LW6 M1P M7P MK4 N04 N05 N9A O9- OIG OK1 OVD P2P P2X P2Z P4B P4D PHGZM PHGZT PIMPY PSQYO Q11 ROL RPM RX1 RYH SJN SUPJJ SV3 TEORI UB1 UKHRP W8V WOW WQJ WXI XG1 ~IA ~WT .55 3O- 53G 7.U 8FE 8FH ABEML ACSCC ACXQS AFFNX AOIJS AVUZU BCNDV DIK HYE IAO IHR IPNFZ ITC LK8 PROAC WIN WRC X7M ZXP AAYXX CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY IQODW PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AZQEC DWQXO GNUQQ K9. PKEHL PQEST PQQKQ PQUKI PUEGO PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c6793-dad774291f74bd78013bedaae491b2a0ebce155c1fdcc6abd272d5e7b66a78d33 |
| IEDL.DBID | 7X7 |
| ISSN | 1347-9032 1349-7006 |
| IngestDate | Thu Aug 21 18:33:13 EDT 2025 Thu Jul 10 18:49:30 EDT 2025 Wed Aug 13 01:33:04 EDT 2025 Sat Aug 23 13:23:53 EDT 2025 Mon Jul 21 06:06:38 EDT 2025 Mon Jul 21 09:15:47 EDT 2025 Thu Apr 24 22:56:47 EDT 2025 Tue Jul 01 01:30:46 EDT 2025 Wed Jan 22 16:46:12 EST 2025 Thu Jun 26 22:56:38 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | Human Oxygen Breast disease Breast cancer Inflammation Malignant tumor Microenvironment Mammary gland diseases Breast carcinoma Cancerology Gene Established cell line Genetics Hypoxia Invasive cancer Cancer Adaptation |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c6793-dad774291f74bd78013bedaae491b2a0ebce155c1fdcc6abd272d5e7b66a78d33 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://www.proquest.com/docview/3121790865?pq-origsite=%requestingapplication% |
| PMID | 20151982 |
| PQID | 2861578874 |
| PQPubID | 4378882 |
| PageCount | 10 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11159242 proquest_miscellaneous_748947306 proquest_journals_3121790865 proquest_journals_2861578874 pubmed_primary_20151982 pascalfrancis_primary_22963651 crossref_citationtrail_10_1111_j_1349_7006_2010_01493_x crossref_primary_10_1111_j_1349_7006_2010_01493_x wiley_primary_10_1111_j_1349_7006_2010_01493_x_CAS1493 nii_cinii_1571135650973435136 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | April 2010 |
| PublicationDateYYYYMMDD | 2010-04-01 |
| PublicationDate_xml | – month: 04 year: 2010 text: April 2010 |
| PublicationDecade | 2010 |
| PublicationPlace | Oxford, UK |
| PublicationPlace_xml | – name: Oxford, UK – name: Richmond – name: England – name: Tokyo |
| PublicationTitle | Cancer science |
| PublicationTitleAlternate | Cancer Sci |
| PublicationYear | 2010 |
| Publisher | Blackwell Publishing Ltd Blackwell John Wiley & Sons, Inc |
| Publisher_xml | – name: Blackwell Publishing Ltd – name: Blackwell – name: John Wiley & Sons, Inc |
| References | 2009; 69 2009; 47 2009; 41 2007; 282 2006; 13 2008; 18 2002; 2 2008; 15 2008; 34 2008; 8 2005; 65 2004; 5 2000; 275 2009; 174 2008; 444 2008; 4 2009; 459 2009; 219 2009; 27 2004; 431 2007; 28 2009; 11 2001; 410 2009; 35 2009; 30 2009; 606 2005; 201 2002; 22 2008; 659 2003; 3 2005; 7 2008; 118 2008; 23 2009; 8 2008; 68 2008; 453 2008; 60 2009; 16 1996; 87 2009; 15 e_1_2_7_5_2 e_1_2_7_4_2 e_1_2_7_3_2 e_1_2_7_2_2 e_1_2_7_9_2 e_1_2_7_8_2 e_1_2_7_7_2 e_1_2_7_6_2 e_1_2_7_19_2 e_1_2_7_18_2 e_1_2_7_17_2 e_1_2_7_16_2 e_1_2_7_15_2 e_1_2_7_14_2 e_1_2_7_40_2 e_1_2_7_13_2 e_1_2_7_41_2 e_1_2_7_12_2 e_1_2_7_42_2 e_1_2_7_11_2 e_1_2_7_10_2 e_1_2_7_26_2 e_1_2_7_27_2 e_1_2_7_28_2 e_1_2_7_29_2 e_1_2_7_25_2 Sonveaux P (e_1_2_7_35_2) 2008; 118 e_1_2_7_24_2 e_1_2_7_30_2 e_1_2_7_23_2 e_1_2_7_31_2 e_1_2_7_22_2 e_1_2_7_32_2 e_1_2_7_21_2 e_1_2_7_33_2 e_1_2_7_20_2 e_1_2_7_34_2 e_1_2_7_36_2 e_1_2_7_37_2 e_1_2_7_38_2 e_1_2_7_39_2 |
| References_xml | – volume: 47 start-page: 55 year: 2009 end-page: 61 article-title: A potential role for reactive oxygen species and the HIF‐1alpha‐VEGF pathway in hypoxia‐induced pulmonary vascular leak publication-title: Free Radic Biol Med – volume: 201 start-page: 105 year: 2005 end-page: 15 article-title: Hypoxia‐induced neutrophil survival is mediated by HIF‐1alpha‐dependent NF‐kappaB activity publication-title: J Exp Med – volume: 219 start-page: 209 year: 2009 end-page: 18 article-title: The Ape‐1/Ref‐1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis publication-title: J Cell Physiol – volume: 35 start-page: 138 year: 2009 end-page: 45 article-title: Pentraxins: multifunctional proteins at the interface of innate immunity and inflammation publication-title: Biofactors – volume: 30 start-page: 205 year: 2009 end-page: 13 article-title: Stromal cell‐derived factor‐1alpha (SDF‐1alpha/CXCL12)‐enhanced angiogenesis of human basal cell carcinoma cells involves ERK1/2‐NF‐kappaB/interleukin‐6 pathway publication-title: Carcinogenesis – volume: 4 start-page: 1042 year: 2008 end-page: 53 article-title: Induction of autophagic cell death by a novel molecule is increased by hypoxia publication-title: Autophagy – volume: 15 start-page: 321 year: 2008 end-page: 6 article-title: Lipoxygenase pathway receptor expression in ovarian cancer publication-title: Reprod Sci – volume: 174 start-page: 1309 year: 2009 end-page: 18 article-title: The long pentraxin PTX3 is crucial for tissue inflammation after intestinal ischemia and reperfusion in mice publication-title: Am J Pathol – volume: 7 start-page: 395 year: 2005 end-page: 403 article-title: Redox regulation of NF‐kappaB activation: distinct redox regulation between the cytoplasm and the nucleus publication-title: Antioxid Redox Signal – volume: 5 start-page: 392 year: 2004 end-page: 401 article-title: Shaping the nuclear action of NF‐kappaB publication-title: Nat Rev Mol Cell Biol – volume: 3 start-page: 721 year: 2003 end-page: 32 article-title: Targeting HIF‐1 for cancer therapy publication-title: Nat Rev Cancer – volume: 68 start-page: 7130 year: 2008 end-page: 6 article-title: Nitric oxide is a key component in inflammation‐accelerated tumorigenesis publication-title: Cancer Res – volume: 444 start-page: 264 year: 2008 end-page: 9 article-title: Baicalein suppresses hypoxia‐induced HIF‐1alpha protein accumulation and activation through inhibition of reactive oxygen species and PI 3‐kinase/Akt pathway in BV2 murine microglial cells publication-title: Neurosci Lett – volume: 15 start-page: 245 year: 2009 end-page: 53 article-title: Epithelial metaplasia: adult stem cell reprogramming and (pre)neoplastic transformation mediated by inflammation? publication-title: Trends Mol Med – volume: 2 start-page: 301 year: 2002 end-page: 10 article-title: NF‐kappaB in cancer: from innocent bystander to major culprit publication-title: Nat Rev Cancer – volume: 23 start-page: 350 year: 2008 end-page: 9 article-title: Inflammation and stem cells in gastrointestinal carcinogenesis publication-title: Physiology (Bethesda) – volume: 8 start-page: 33 year: 2009 end-page: 40 article-title: Is NF‐kappaB a good target for cancer therapy? Hopes and pitfalls publication-title: Nat Rev Drug Discov – volume: 275 start-page: 25781 year: 2000 end-page: 90 article-title: The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor‐alpha through nuclear factor‐kappa B, and by 17beta‐estradiol through Sp‐1 in human vascular endothelial cells publication-title: J Biol Chem – volume: 87 start-page: 13 year: 1996 end-page: 20 article-title: NF‐kappa B: ten years after publication-title: Cell – volume: 41 start-page: 51 year: 2009 end-page: 8 article-title: Regulation of glucose metabolism‐related genes and VEGF by HIF‐1alpha and HIF‐1beta, but not HIF‐2alpha, in gastric cancer publication-title: Exp Mol Med – volume: 18 start-page: 591 year: 2008 end-page: 9 article-title: Inflammation: its role and interplay in the development of cancer, with special focus on gynecological malignancies publication-title: Int J Gynecol Cancer – volume: 22 start-page: 2862 year: 2002 end-page: 70 article-title: NF‐kappa B activates prostate‐specific antigen expression and is upregulated in androgen‐independent prostate cancer publication-title: Mol Cell Biol – volume: 606 start-page: 45 year: 2009 end-page: 9 article-title: The redox state of glutathione regulates the hypoxic induction of HIF‐1 publication-title: Eur J Pharmacol – volume: 453 start-page: 807 year: 2008 end-page: 11 article-title: NF‐kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF‐1alpha publication-title: Nature – volume: 8 start-page: 279 year: 2008 end-page: 89 article-title: How dying cells alert the immune system to danger publication-title: Nat Rev Immunol – volume: 459 start-page: 1005 year: 2009 end-page: 9 article-title: Genes that mediate breast cancer metastasis to the brain publication-title: Nature – volume: 282 start-page: 36330 year: 2007 end-page: 40 article-title: Hypoxia‐inducible factor‐1 mediates neuronal expression of the receptor for advanced glycation end products following hypoxia/ischemia publication-title: J Biol Chem – volume: 659 start-page: 15 year: 2008 end-page: 30 article-title: Inflammation: gearing the journey to cancer publication-title: Mutat Res – volume: 65 start-page: 6493 year: 2005 end-page: 7 article-title: CXCL‐12/stromal cell‐derived factor‐1alpha transactivates HER2‐neu in breast cancer cells by a novel pathway involving Src kinase activation publication-title: Cancer Res – volume: 69 start-page: 1245 year: 2009 end-page: 55 article-title: Up‐regulation of the inflammatory‐reparative phenotype in human prostate carcinoma publication-title: Prostate – volume: 2 start-page: 664 year: 2002 end-page: 74 article-title: Nf‐kappa B, chemokine gene transcription and tumour growth publication-title: Nat Rev Immunol – volume: 60 start-page: 591 year: 2008 end-page: 7 article-title: Hypoxia‐inducible factor 1 and cancer pathogenesis publication-title: IUBMB Life – volume: 28 start-page: 465 year: 2007 end-page: 72 article-title: Liaisons dangereuses: P2X(7) and the inflammasome publication-title: Trends Pharmacol Sci – volume: 13 start-page: 118 year: 2006 end-page: 37 article-title: The inflammatory tumor microenvironment and its impact on cancer development publication-title: Contrib Microbiol – volume: 431 start-page: 461 year: 2004 end-page: 6 article-title: NF‐kappaB functions as a tumour promoter in inflammation‐associated cancer publication-title: Nature – volume: 118 start-page: 3930 year: 2008 end-page: 42 article-title: Targeting lactate‐fueled respiration selectively kills hypoxic tumor cells in mice publication-title: J Clin Invest – volume: 16 start-page: 440 year: 2009 end-page: 6 article-title: Expression of receptor for advanced glycation end products (RAGE) is related to prognosis in patients with esophageal squamous cell carcinoma publication-title: Ann Surg Oncol – volume: 410 start-page: 50 year: 2001 end-page: 6 article-title: Involvement of chemokine receptors in breast cancer metastasis publication-title: Nature – volume: 11 start-page: 125 year: 2009 end-page: 31 article-title: The chemokine receptors CXCR4 and CXCR3 in cancer publication-title: Curr Oncol Rep – volume: 27 start-page: 693 year: 2009 end-page: 733 article-title: Regulation and function of NF‐kappaB transcrip‐tion factors in the immune system publication-title: Annu Rev Immunol – volume: 34 start-page: 689 year: 2008 end-page: 92 article-title: RAGE mRNA expression and its correlation with nuclear factor kappa beta mRNA expression in inflamed human periradicular tissues publication-title: J Endod – ident: e_1_2_7_30_2 doi: 10.1016/S0092-8674(00)81318-5 – volume: 118 start-page: 3930 year: 2008 ident: e_1_2_7_35_2 article-title: Targeting lactate‐fueled respiration selectively kills hypoxic tumor cells in mice publication-title: J Clin Invest – ident: e_1_2_7_13_2 doi: 10.1038/nrd2781 – ident: e_1_2_7_27_2 doi: 10.1038/nrm1368 – ident: e_1_2_7_14_2 doi: 10.1007/s11912-009-0019-1 – ident: e_1_2_7_22_2 doi: 10.1245/s10434-008-0237-z – ident: e_1_2_7_5_2 doi: 10.1038/nrc780 – ident: e_1_2_7_7_2 doi: 10.1038/nri887 – ident: e_1_2_7_32_2 doi: 10.1038/nrc1187 – ident: e_1_2_7_9_2 doi: 10.3858/emm.2009.41.1.007 – ident: e_1_2_7_20_2 doi: 10.2353/ajpath.2009.080240 – ident: e_1_2_7_41_2 doi: 10.1152/physiol.00031.2008 – ident: e_1_2_7_42_2 doi: 10.1016/j.molmed.2009.04.002 – ident: e_1_2_7_29_2 doi: 10.1016/j.tips.2007.07.002 – ident: e_1_2_7_33_2 doi: 10.1089/ars.2005.7.395 – ident: e_1_2_7_36_2 doi: 10.1002/jcp.21666 – ident: e_1_2_7_2_2 doi: 10.1038/nature06905 – ident: e_1_2_7_10_2 doi: 10.1074/jbc.M706407200 – ident: e_1_2_7_34_2 doi: 10.1016/j.neulet.2008.08.057 – ident: e_1_2_7_28_2 doi: 10.1074/jbc.M001235200 – ident: e_1_2_7_37_2 doi: 10.1016/j.ejphar.2009.01.026 – ident: e_1_2_7_38_2 doi: 10.1159/000092969 – ident: e_1_2_7_24_2 doi: 10.1038/35065016 – ident: e_1_2_7_8_2 doi: 10.1016/j.freeradbiomed.2009.03.027 – ident: e_1_2_7_31_2 doi: 10.1146/annurev.immunol.021908.132641 – ident: e_1_2_7_3_2 doi: 10.1002/pros.20966 – ident: e_1_2_7_23_2 doi: 10.4161/auto.7070 – ident: e_1_2_7_18_2 doi: 10.1177/1933719108316390 – ident: e_1_2_7_15_2 doi: 10.1093/carcin/bgn228 – ident: e_1_2_7_16_2 doi: 10.1038/nature08021 – ident: e_1_2_7_21_2 doi: 10.1016/j.joen.2008.02.013 – ident: e_1_2_7_40_2 doi: 10.1111/j.1525-1438.2007.01089.x – ident: e_1_2_7_25_2 doi: 10.1158/0008-5472.CAN-04-1303 – ident: e_1_2_7_19_2 doi: 10.1002/biof.21 – ident: e_1_2_7_6_2 doi: 10.1038/nature02924 – ident: e_1_2_7_26_2 doi: 10.1002/iub.93 – ident: e_1_2_7_39_2 doi: 10.1016/j.mrrev.2008.03.002 – ident: e_1_2_7_4_2 doi: 10.1128/MCB.22.8.2862-2870.2002 – ident: e_1_2_7_11_2 doi: 10.1084/jem.20040624 – ident: e_1_2_7_17_2 doi: 10.1158/0008-5472.CAN-08-0410 – ident: e_1_2_7_12_2 doi: 10.1038/nri2215 |
| SSID | ssj0036494 |
| Score | 2.201125 |
| Snippet | The role of tumor cells in synthesizing pro‐inflammatory molecules is still controversial. Here we report that hypoxic treatment of the MCF‐7 human mammary... The role of tumor cells in synthesizing pro-inflammatory molecules is still controversial. Here we report that hypoxic treatment of the MCF-7 human mammary... |
| SourceID | pubmedcentral proquest pubmed pascalfrancis crossref wiley nii |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1014 |
| SubjectTerms | Acute phase proteins Adenocarcinoma Advanced glycosylation end products Aged Antibodies Biological and medical sciences Breast Neoplasms - genetics Breast Neoplasms - immunology Breast Neoplasms - metabolism Cell activation Cell Hypoxia - genetics Cell Line, Tumor Cell migration Chemokines CXCR4 protein Cyclooxygenase-2 Cytokines Enzymes Estrogen receptors Female Fibroblast growth factor 2 Gene expression Gene regulation Genes Genotype & phenotype Glycosylation Goats Growth factors Gynecology. Andrology. Obstetrics Humans Hypoxia Hypoxia-Inducible Factor 1, alpha Subunit - metabolism Hypoxia-inducible factor 1a Inflammation Inflammation - genetics Invasiveness Mammary gland Mammary gland diseases Medical sciences Middle Aged Neoplasm Invasiveness - genetics NF-kappa B - antagonists & inhibitors NF-kappa B - genetics NF-kappa B - metabolism NF-κB protein Nitric-oxide synthase Nuclear transport Original Pentraxins Phenotypes Proteins Transcription Transcription activation Transformed cells Tumor cells Tumor microenvironment Tumors Up-Regulation |
| SummonAdditionalLinks | – databaseName: Wiley Online Library - Core collection (SURFmarket) dbid: DR2 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LjtMwFLVgFogN70dgZuQF21T1I3ayHFVUI6SyACrNzrJjZyYamlTTFg2s-ALEN_Il3JukoRm6GCGkqqrsOElvrq-P4-NzCXmTCcdDIl2cF-NxLEWhY-tZFhdB5ijgrUQjuzh7r07n8t1Zctbxn3AvTKsP0b9ww57RxGvs4Nathp1cyCzWuJzQMrQA7IsR4kmkbiE--tArSQklsza_rdRxNhY3SD17TzQYqe5WZYm8SbsC0xVtzot9oPRvbuUu5m0GrelDcrn9uy1X5XK0WbtR_u2GEuT_sccj8qDDtvSkdcbH5E6onpB7s271_in5MV_--v7zKpx3KcNoXVC4NSgDNwfPXDQr_vQcwy-18PF22TIF6LqmF1-X9XVpaVnR2WQKjTTFVQc4rPJY2GQbpAvbbMaDgi8Wmfk0x2RJVb2wdIHcw52Nfc_IfPr20-Q07vJBxLmCMBJ76wGs8owVWjqvYWwVLnhrg8yY43YcXB4AHuWs8HmurPNcc58E7ZSyOvVCPCcHVV2Fl4RqQHGAbGxQGjCK9zaBgVo5mG4oL6UXEdHbZ2_yTiwdc3Z8NjuTJjC3QXMbNLdpzG2uI8L6lstWMOQWbY7AveBC-M0SzZhIUNlQCwCz4MwROR44Xn9iziF-qoRF5HDriaaLQSvDU0CrSBaVe6sF46jOlqokIrSvhuCCz85Wod6sDEoTSRgD4A5etG7959KAI1mW8oikA4fvD0Dd8mFNVV40-uVgigSm_dBUNQ59azuZyclH_PXqXxu-Jvdb9gcyrw7JwfpqE44AVK7dcRMufgMG2mmK priority: 102 providerName: Wiley-Blackwell |
| Title | Up-regulation of pro-inflammatory genes as adaptation to hypoxia in MCF-7 cells and in human mammary invasive carcinoma microenvironment |
| URI | https://cir.nii.ac.jp/crid/1571135650973435136 https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1349-7006.2010.01493.x https://www.ncbi.nlm.nih.gov/pubmed/20151982 https://www.proquest.com/docview/2861578874 https://www.proquest.com/docview/3121790865 https://www.proquest.com/docview/748947306 https://pubmed.ncbi.nlm.nih.gov/PMC11159242 |
| Volume | 101 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1fa9swEBdLC2MvY__nrg162KtY9MeS_VS6rKEMUkq3QN6MbMmrobG9Jh3d2z7B2GfcJ9md7bjJVkYhhESyrER3Ov2kO_-OkLexTIUPVcqyfDRiSuaGWcdjlnuVIYG3lg3t4vRUn8zUx3k47w7cll1Y5domNobaVRmekb-TXCCZVKTDw_orw6xR6F3tUmgMyC5Sl6FWm3m_4ZJaxW1SW2VYPJJ_RfJIFTODzog2vgu2CnJNgNQtT4OyKDBY0i5hvPI20cVdSPTfgMpNoNusVJMn5HEHMelRqxNPyQNfPiMPp50T_Tn5Oat___h11SahB7HQKqfQGZSBtoGCLBrHO_2CVpBaeDlbtw57uqroxfe6uiksLUo6HU-gkaF4-A-XlQ4Lm6R_dGGbZ-Kg4JvFAHmaYc6islpYusAQwI3n616Q2eT48_iEdWkZWKZhNjNnHWBGEfPcqNQZWOJk6p21XsU8FXbk08wDSsl47rJM29QJI1zoTaq1NZGT8iXZKavSvybUAJgCgGG9NgAVnLMhrJc6BdSvnVJOBsSspZFkHWc5ps64TDb2LiDHBOWYoByTRo7JTUB437JueTvu0eYABA4d4TsPDecyRIJBIwFTcqkDMtxShf7GQoAZ0yEPyP5aN5LOFCwTEQFoxJhNdWf1rV4HhPbVMMdRdrb01fUyQYYgBaYYfsGrVtFuuwY4x-NIBCTaUsH-AqQP364pi4uGRhyGIoTdNzTVjbbee5yS8dEn_LT3___zhjxqQy0wzGmf7Kyurv0BILhVOiQDoc6GzWQdkt33x6dn5_Dtw7n4A5h3Q-8 |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEF6VIgEXxD-GtuwBjhbZH-_GB4SqQJTSphcaKbdl7V23kYjtNmlpbzwB4kl4KJ6EGf-kCVSol0pRFK292cTzefYb77czhLyORcJ9JJMwzTqdUIpMh9axOMy8TDGBtxJV2sXhvhqM5KdxNF4jv9q9MCirbH1i5ahdkeIz8reCcUwm1VXR-_I4xKpRuLraltCoYbHrL75ByDZ7t_MB7PuG8_7Hg94gbKoKhKkCMIbOOqA8PGaZlonT4KFF4p21XsYs4bbjk9TDJJuyzKWpsonjmrvI60Qpq7sOH4CCy78NE28Hgz09XgR4Qsm4LqIrdRh3xF_KISHjUOPiR60ng9BEtAmXmunwVj6ZoDjTzsA-WV1Y4yrm-6-Ac5lYVzNj_wG531Baul1j8CFZ8_kjcmfYLNo_Jj9G5e_vP0_qovcAA1pkFAaDNkA3AHJaLfTTQ_S61MLL2bIWCNB5QY8uyuJ8Yukkp8NeHzppiosNcFrusLEqMkinttqDBw1nFgX5NMUaSXkxtXSKksOl_XxPyOhGDPaUrOdF7p8TqoG8AaGxXmmgJs7ZCOZnlUCUoZyUTgREt9YwaZMjHUt1fDVLsRLY0aAdDdrRVHY05wFhi55lnSfkGn02weAwEL6zSDMmIkxoqAVwWCZUQLZWoLD4Ys7BbaqIBWSjxYZpXM_M8C6QVNSIyisPX95HAaGLw-BT0HY298XpzGBGIgmuH37Bsxpol0MDfWRxlwekuwLBxQmYrnz1SD45qtKWw6WIINqHrqpC67Wvk-ltf8ZPL_7_f16Ru4OD4Z7Z29nffUnu1TIPlFhtkPX5yanfBPY4T7aqW5aSLzftI_4AEa1_SA |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEF6VVKq4IP4xtGUPcLSa_fFufECopI1aSqIKiNTbsvau20jEDk0K7Y0nQDwPj8OTMOOfNIEK9VIpsqJdbzb2jGe-8X47Q8iLWCTcRzIJ06zdDqXIdGgdi8PMyxQTeCtRpl3sD9TeUL49io5WyK9mLwzSKhubWBpqV6T4jnxLMI7JpDoq2spqWsThTu_15EuIFaRwpbUpp1GpyIG_-Abh2_TV_g7I-iXnvd2P3b2wrjAQpgoUM3TWAfzhMcu0TJwGay0S76z1MmYJt22fpB4cbsoyl6bKJo5r7iKvE6Ws7jh8GQrmf1VjVNQiq292B4fvGz8glIyrkrpSh3Fb_MUjEjIONS6FVOwyCFREk36pdo638tEIqZp2CtLKqjIbV-Hgf-mcizC79JO9u-RODXDpdqWR98iKz--TtX69hP-A_BhOfn__eeqP67phtMgoTAZtoOugnuNy2Z8eow2mFj7OTiq6AJ0V9ORiUpyPLB3ltN_twSBNcekBTssdNpYlB-nYljvyoOGrRXo-TbFiUl6MLR0jAXFhd99DMrwRkT0irbzI_RNCNUA5gDfWKw1AxTkbgbdWCcQcyknpREB0Iw2T1hnTsXDHZ7MQOYEcDcrRoBxNKUdzHhA2HzmpsoZcY8wGCBwmwiOLNGMiwvSGWgCiZUIFZHNJFeY_zDkYURWxgKw3umFqQzQ1vAOQFRmj8sruy6cqIHTeDRYGZWdzX5xNDeYnkuAI4B88rhTtcmoAkyzu8IB0llRwfgImL1_uyUcnZRJzuBURxP4wVJXaeu37ZLrbH_Db0_9fz3OyBvbBvNsfHDwjtyvOB_Kt1klrdnrmNwBKzpLN-pml5NNNm4k_skeE4w |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Up-regulation+of+pro-inflammatory+genes+as+adaptation+to+hypoxia+in+MCF-7+cells+and+in+human+mammary+invasive+carcinoma+microenvironment&rft.jtitle=Cancer+science&rft.au=TAFANI+Marco&rft.au=RUSSO+Andrea&rft.au=DI+VITO+Maura&rft.au=SALE+Patrizio&rft.date=2010-04-01&rft.issn=1347-9032&rft.volume=101&rft.issue=4&rft.spage=1014&rft.epage=1023&rft_id=info:doi/10.1111%2Fj.1349-7006.2010.01493.x&rft.externalDocID=10026591346 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1347-9032&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1347-9032&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1347-9032&client=summon |